Fellowship · Tampa, FL
Sponsored by University of South Florida Morsani College of Medicine
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 111 citations · Vaagn Andikyan
Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical Trial.
JAMA internal medicine · 2025 · 19 citations · Matthew Anderson
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Proceedings of the National Academy of Sciences of the United States of America · 2021 · 105 citations · Vaagn Andikyan
PARP Inhibitors in Ovarian Cancer: Resistance Mechanisms, Clinical Evidence, and Evolving Strategies.
Biomedicines · 2025 · 19 citations · Maya Yasukawa, Lindsey Nguy, Vaagn Andikyan, Matthew Anderson, Thomas Rutherford, Adrian Kohut
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Cancer · 2022 · 64 citations · Vaagn Andikyan
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.
American journal of preventive medicine · 2024 · 17 citations · Matthew Anderson
A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy.
Scientific reports · 2025 · 11 citations · Katelyn Handley
Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population.
Annals of oncology : official journal of the European Society for Medical Oncology · 2025 · 13 citations · Katelyn Handley